Waters Teams With Biochemical Society on Proteomics Training Day and Symposium

Dates and Agenda Set, Registration Now Open for Quantitative Proteomics and ProteoMMX 3.0 Events

News provided by

Nov 27, 2013, 10:00 ET

MILFORD, Mass., Nov. 27, 2013 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the Biochemical Society announced today the opening of registration for the Biochemical Society's Quantitative Proteomics Training Day and the ProteoMMX 3.0 Symposium, consecutive events taking place March 24 - 27, 2014 in Chester, England. The Quantitative Proteomics Training Day is aimed at researchers seeking to gain familiarity with the field of quantitative proteomics. ProteoMMX 3.0, following immediately after the Training Day, is dedicated to current thinking and state of the art research in quantitative proteomics.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)

Professor Rob Beynon at the Institute of Integrative Biology at the University of Liverpool is leading the Organizing Committee. "The Symposium really gets to grips with the nuances and uncertainties in quantitative mass spectrometry-based proteomics in a friendly and supportive meeting. It is particularly suitable for early career researchers and newcomers to the field, especially if they attend the Training Day preceding the Symposium," said Prof. Beynon.

The Symposium has been held three times previously with great success. Waters Corporation is the Enabling Sponsor of the ProteoMMX 3.0 Symposium.

About Proteomics and Mass Spectrometry
Proteomics is the large-scale study of proteins in biological systems. Mass spectrometry-enabled proteomics can identify large numbers of proteins in complex systems but there is a pressing need to support identification with precise and accurate quantification, whether globally – every protein - or in a targeted - specific proteins - fashion. By enabling proteomics experiments, mass spectrometry helps develop our understanding of the function of proteins in a living organism in normal physiology and in disease.

About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters is a trademark of Waters Corporation.

SOURCE Waters Corporation